Volume 11, Number 1—January 2005
Anti–SARS-CoV Immunoglobulin G in Healthcare Workers, Guangzhou, China
|SARS-related information||First Affiliated Hospital||Second Affiliated Hospital||Third Affiliated Hospital||Affiliated Cancer Hospital||Fifth Affiliated Hospital|
|In SARS-epidemic area?||Yes||Yes||Yes||Yes||No|
|No. healthcare workers exposed to SARS*||548||421||425||0||0|
|No. healthcare workers surveyed||389||361||397||371||338|
|No. days when SARS patients were in the hospital||120||110||102||0||0|
|No. probable SARS patients cared for||122||150||31||0||0|
|No. suspected SARS patients cared for||102||50||30||3||0|
|No. SARS patients who required tracheal intubation||10||0||1||0||0|
|No. SARS patients who required tracheotomy||0||1||2||0||0|
|Cared for the index patient?†||No||Yes||Yes||0||0|
|No. healthcare workers who had SARS‡ in SARS wards||0||80||20||0||0|
|No. healthcare workers who had from SARS in non-SARS wards||3||10||2||0||0|
*This refers to healthcare workers caring for SARS patients and laboratory personnel handling specimens from SARS patients.
†The index patient was identified as a superspreader who subsequently infected >100 persons (both healthcare workers and other patients and family members in the Second Hospital and Third Hospital).
‡According to the clinical and epidemiologic case definition.
- Page created: April 14, 2011
- Page last updated: April 14, 2011
- Page last reviewed: April 14, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)